Pfizer Inc - SWOT Analysis

Pfizer Inc - SWOT Analysis
  • Report price : $ 125
  • Publication date : April 2008
  • Length : 45 pages

Get this Report Now !

Pfizer Inc - SWOT Analysis

Datamonitor's Pfizer Inc - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Pfizer, one of the largest pharmaceutical companies, discovers, develops, manufactures and markets prescription medicines for humans and animals. The company operates in more than 150 countries. Pfizer is headquartered in New York City, New York and employs about 98,000 people. The company recorded revenues of $48,371 million during the fiscal year ended December 2006, an increase of 2% over 2005. The increase was primarily due to the strong performance by the company’s new products over the past three years. The operating profit of the company was $12,124 million during fiscal year 2006, an increase of 8.3% over 2005. The net profit was $19,337 million in fiscal year 2006, as compared to a net profit of $8,085 in 2005.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available

RELATED REPORTS

Santarus, Inc. - SWOT Analysis

Santarus, Inc. - SWOT Analysis

  • $ 125
  • April 2008
  • 23 pages

Datamonitor's Santarus, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Sant ...

Industries : Pharmaceutical | Countries : USA

Amgen Inc. - SWOT Analysis

Amgen Inc. - SWOT Analysis

  • $ 125
  • April 2008
  • 37 pages

Datamonitor's Amgen Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Amgen is ...

Industries : Pharmaceutical | Countries : USA

ISTA Pharmaceuticals, Inc. - SWOT Analysis

ISTA Pharmaceuticals, Inc. - SWOT Analysis

  • $ 125
  • April 2008
  • 24 pages

Datamonitor's ISTA Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and st ...

Industries : Pharmaceutical | Countries : USA

Cardinal Health, Inc. - SWOT Analysis

Cardinal Health, Inc. - SWOT Analysis

  • $ 125
  • April 2008
  • 39 pages

Datamonitor's Cardinal Health, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strateg ...

Industries : Pharmaceutical | Countries : USA

Endo Pharmaceuticals Holdings Inc. - SWOT Analysis

Endo Pharmaceuticals Holdings Inc. - SWOT Analysis

  • $ 125
  • April 2008
  • 26 pages

Datamonitor's Endo Pharmaceuticals Holdings Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue line ...

Industries : Pharmaceutical | Countries : USA

Nastech Pharmaceutical Company Inc - SWOT Analysis

Nastech Pharmaceutical Company Inc - SWOT Analysis

  • $ 125
  • April 2008
  • 25 pages

Datamonitor's Nastech Pharmaceutical Company Inc - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue line ...

Industries : Pharmaceutical | Countries : USA

CollaGenex Pharmaceuticals, Inc. - SWOT Analysis

CollaGenex Pharmaceuticals, Inc. - SWOT Analysis

  • $ 125
  • April 2008
  • 25 pages

Datamonitor's CollaGenex Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines ...

Industries : Pharmaceutical | Countries : USA

Biogen Idec, Inc. - SWOT Analysis

Biogen Idec, Inc. - SWOT Analysis

  • $ 125
  • April 2008
  • 27 pages

Datamonitor's Biogen Idec, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. B ...

Industries : Pharmaceutical | Countries : USA

Insulin Delivery Systems Market Analysis (2007-2010)

Insulin Delivery Systems Market Analysis (2007-2010)

  • $ 1 400
  • January 2008
  • 250 pages

The research report “Insulin Delivery Systems Market Analysis (2007-2010)” by RNCOS gives an exhaustive analysis on the global insulin market and various Insulin delivery methods. The report investigates the market for various devices used for delivering insulin, including syringes, pens, pumps, ...

Industries : Medical Devices, Pharmaceutical | Countries : Egypt, Mexico, Brazil, USA, China, Japan, India, Pakistan, Russia, Germany

Live-Licensing and In-life testing: R and D Processes and Regulation for New Drugs, 2008-2020

Live-Licensing and In-life testing: R and D Processes and Regulation for New Drugs, 2008-2020

  • $ 2 501
  • January 2008
  • 250 pages

Visiongain predict that the current phase I to IV clinical testing process will eventually be selectively or wholly replaced by a system known as “in-life” testing or “live” licensing. Those proposals involve cumulative testing of the drug throughout its lifecycle. The industry would continu ...

Industries : Pharmaceutical | Countries : USA, Japan, Germany, United Kingdom

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.